HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linling Wang Selected Research

Cucurbitacins

1/2013Growth inhibitory effect of Cucurbitacin E on breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Linling Wang Research Topics

Disease

8Neoplasms (Cancer)
03/2023 - 01/2013
3Breast Neoplasms (Breast Cancer)
04/2023 - 01/2013
3Infections
08/2021 - 02/2012
2Neoplasm Metastasis (Metastasis)
01/2021 - 01/2020
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2023
1Carcinoma (Carcinomatosis)
01/2023
1Human Influenza (Influenza)
02/2022
1Lung Diseases (Lung Disease)
02/2022
1Cholangiocarcinoma
01/2022
1Invasive Fungal Infections
01/2022
1Hematologic Neoplasms (Hematological Malignancy)
01/2022
1Glaucoma
01/2021
1Adenocarcinoma of Lung
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020
1Pathologic Complete Response
01/2020
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2019
1Lung Neoplasms (Lung Cancer)
01/2019
1Stomach Neoplasms (Stomach Cancer)
11/2016
1Inflammation (Inflammations)
01/2013
1Carcinogenesis
01/2013

Drug/Important Bio-Agent (IBA)

3Chimeric Antigen ReceptorsIBA
03/2023 - 01/2020
3Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2012
1Silicon Dioxide (Silica)FDA LinkGeneric
04/2023
1Irinotecan (Camptosar)FDA LinkGeneric
04/2023
1Carcinoembryonic AntigenIBA
01/2023
1AntigensIBA
01/2023
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1posaconazoleFDA Link
01/2022
1Itraconazole (Sporanox)FDA LinkGeneric
01/2022
1Fluconazole (Zonal)FDA LinkGeneric
01/2022
1lenvatinibIBA
01/2022
1TriazolesIBA
01/2022
1SuspensionsIBA
01/2022
1LipidsIBA
08/2021
1SphingolipidsIBA
08/2021
1EnzymesIBA
08/2021
1Caspase 3 (Caspase-3)IBA
01/2021
1Long Noncoding RNAIBA
01/2021
1MatrinesIBA
01/2020
1TOR Serine-Threonine KinasesIBA
01/2019
1Growth Factor ReceptorsIBA
01/2019
1Mechanistic Target of Rapamycin Complex 1IBA
01/2019
1ibrutinibIBA
01/2019
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2019
1Adenosine Triphosphate (ATP)IBA
01/2018
1LactonesIBA
01/2018
1SesquiterpenesIBA
01/2018
1ethyl acetateIBA
01/2018
1Fatty Acids (Saturated Fatty Acids)IBA
01/2018
1Coloring Agents (Dyes)IBA
11/2016
1Celecoxib (Celebrex)FDA Link
11/2016
1ABT-737IBA
11/2016
1lissamine rhodamine B (sulforhodamine B)IBA
11/2016
1DAPIIBA
11/2016
1cucurbitacin EIBA
01/2013
1CucurbitacinsIBA
01/2013
1Cisplatin (Platino)FDA LinkGeneric
01/2013

Therapy/Procedure

4Therapeutics
04/2023 - 01/2022
2Drug Therapy (Chemotherapy)
01/2022 - 11/2016
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2020
1Aftercare (After-Treatment)
11/2016